228 related articles for article (PubMed ID: 26999428)
1. Mixed adenoneuroendocrine carcinoma (MANEC) of the gastroesophageal junction: a case report and review of the literature.
Juanmartiñena JF; Fernández-Urién I; Córdoba A; Miranda C; Borda A
Rev Esp Enferm Dig; 2017 Feb; 109(2):160-162. PubMed ID: 26999428
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
[TBL] [Abstract][Full Text] [Related]
3. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
4. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
5. Parotid metastasis from a gastroesophageal carcinoma: report of a case.
Schoneveld JM; Hesp WL; Teune TM
Dig Surg; 2007; 24(1):68-9. PubMed ID: 17369685
[TBL] [Abstract][Full Text] [Related]
6. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
Gao R; Chen XY; Jin L
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
[No Abstract] [Full Text] [Related]
7. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Mason DP; Rodriguez CP; Ives DI
J Thorac Oncol; 2009 Oct; 4(10):1264-9. PubMed ID: 19668013
[TBL] [Abstract][Full Text] [Related]
8. Mixed adenoneuroendocrine carcinoma (MANEC) of the esophagogastric junction predominantly consisting of poorly differentiated neuroendocrine carcinoma.
Veits L; Lang-Schwarz C; Volkholz H; Falkeis C; Vieth M; Schulz H
Endoscopy; 2013; 45 Suppl 2 UCTN():E16-7. PubMed ID: 23468146
[No Abstract] [Full Text] [Related]
9. Clinically staged cT2 adenocarcinomas of the gastroesophageal junction: accuracy of staging and therapeutic consequences.
Vallböhmer D; Sisic L; Blank S; Kraus S; Stoecklein NH; Knoefel WT; Büchler MW; Ott K
Oncol Res Treat; 2014; 37(3):97-104. PubMed ID: 24685912
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of Cisplatin.
Golombek T; Henker R; Rehak M; Quäschling U; Lordick F; Knödler M
Oncol Res Treat; 2019; 42(3):123-127. PubMed ID: 30799422
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
12. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
13. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM
Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837
[TBL] [Abstract][Full Text] [Related]
14. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
15. Collision tumor with three components at esophagogastric junction.
Pai SA; Kher N; Krishnamurthy S
Indian J Gastroenterol; 1997 Jul; 16(3):116. PubMed ID: 9248193
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction.
Zhao Q; Li Y; Wang J; Zhang J; Qiao X; Tan B; Tian Y; Shi G; Xu Q; Li R; Liu Y; Yang P
Am J Med Sci; 2015 Jun; 349(6):472-6. PubMed ID: 25996101
[TBL] [Abstract][Full Text] [Related]
17. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
[No Abstract] [Full Text] [Related]
19. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.
Kleinberg L; Brock M; Gibson M
Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428
[TBL] [Abstract][Full Text] [Related]
20. Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer - Review article.
Klevebro F; Ekman S; Nilsson M
Surg Oncol; 2017 Sep; 26(3):290-295. PubMed ID: 28807249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
